Sunshine Biopharma, Inc (SBFM) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 53 transactions totaling $295.5K, demonstrating a bullish sentiment with $36.3K in net insider flow. The most recent transaction on Mar 4, 2024 involved a purchase of 100,000 shares valued at $10.0K.
No significant insider buying has been recorded for SBFM in the recent period.
No significant insider selling has been recorded for SBFM in the recent period.
Based on recent SEC filings, insider sentiment for SBFM is bullish with an Insider Alignment Score of 56/100 and a net flow of $36.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Sunshine Biopharma, Inc (SBFM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading SBFM stock, having executed 53 transactions in the past 90 days. The most active insider is Steve N. Slilaty (Executive), who has made 24 transactions totaling $547.8K.
Get notified when executives and directors at SBFM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | N. Slilaty Steve | Executive | Purchase | 100,000 | $0.10 | $10.0K | |
| Feb 8, 2024 | N. Slilaty Steve | Executive | Purchase | 20,000 | $0.10 | $2.0K | |
| Nov 30, 2022 | Sebaaly Camille | Executive | Purchase | 30,000 | $0.76 | $22.8K | |
| Jun 3, 2022 | Sebaaly Camille | Executive | Purchase | 25,000 | $1.22 | $30.5K | |
| Feb 18, 2022 | N. Slilaty Steve | Executive | Disposition | 990,000 | $0.10 | $99.0K | |
| Jan 6, 2021 | Sebaaly Camille | Executive | Award | 20,000,000 | $N/A | $0 | |
| Jan 6, 2021 | N. Slilaty Steve | Executive | Award | 20,000,000 | $N/A | $0 | |
| Jan 6, 2021 | Merzouki Abderrazzak | Executive | Award | 20,000,000 | $N/A | $0 | |
| Jun 17, 2020 | N. Slilaty Steve | Executive | Award | 500,000 | $0.10 | $50.0K | |
| Dec 31, 2019 | N. Slilaty Steve | Executive | Other | 323,673 | $N/A | $0 | |
| Dec 31, 2019 | Sebaaly Camille | Executive | Award | 323,673 | $N/A | $0 | |
| Dec 19, 2019 | N. Slilaty Steve | Executive | Award | 1,300,000 | $N/A | $0 | |
| Dec 19, 2019 | Merzouki Abderrazzak | Executive | Award | 1,300,000 | $N/A | $0 | |
| Dec 19, 2019 | Sebaaly Camille | Executive | Award | 1,300,000 | $N/A | $0 | |
| Oct 20, 2019 | N. Slilaty Steve | Executive | Award | 1,100,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 6 | $165.9K | 27.6% |
Other(J) | 8 | $156.6K | 26.0% |
Sale(S) | 1 | $129.6K | 21.6% |
Disposition(D) | 1 | $99.0K | 16.5% |
Award(A) | 35 | $50.0K | 8.3% |
Conversion(C) | 2 | $0 | 0.0% |
Insider activity at Sunshine Biopharma, Inc shows mixed signals across all time. While $165.9K in purchases indicates some executive confidence,$129.6K in sales balances the picture, resulting in a modest net flow of $36.3K.4 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Steve N. Slilaty, has transacted $547.8K during this period.